Fredag 2 Maj | 04:38:20 Europe / Stockholm

Kalender

Est. tid*
2026-02-26 08:30 Bokslutskommuniké 2025
2025-11-28 08:30 Kvartalsrapport 2025-Q3
2025-08-28 08:30 Kvartalsrapport 2025-Q2
2025-06-19 N/A X-dag ordinarie utdelning AXIC A 0.00 SEK
2025-06-18 N/A Årsstämma
2025-05-22 08:30 Kvartalsrapport 2025-Q1
2025-02-27 - Bokslutskommuniké 2024
2024-11-28 - Kvartalsrapport 2024-Q3
2024-08-27 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2024-06-19 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-03-06 - Extra Bolagsstämma 2024
2024-03-05 - Bokslutskommuniké 2023
2023-11-22 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-06-19 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2023-06-16 - Årsstämma
2023-05-24 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2022-05-31 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-31 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2021-05-28 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-24 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2020-05-26 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2019-05-28 - Årsstämma
2019-05-23 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2018-05-31 - Årsstämma
2018-05-15 - Kvartalsrapport 2018-Q1
2018-02-27 - Bokslutskommuniké 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2017-05-31 - Årsstämma
2017-05-31 - Kvartalsrapport 2017-Q1
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-24 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2016-05-23 - Årsstämma
2016-05-19 - Kvartalsrapport 2016-Q1
2016-02-25 - Bokslutskommuniké 2015
2015-11-25 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2015-05-28 - Årsstämma
2015-05-25 - Kvartalsrapport 2015-Q1
2015-02-26 - Bokslutskommuniké 2014
2014-11-24 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-05-22 - Årsstämma
2014-05-22 - Kvartalsrapport 2014-Q1
2014-02-28 - Bokslutskommuniké 2013
2013-11-29 - Kvartalsrapport 2013-Q3
2013-08-26 - Kvartalsrapport 2013-Q2
2013-06-28 - Split AXIC A 4:1
2013-05-30 - Kvartalsrapport 2013-Q1
2013-05-21 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2013-05-20 - Årsstämma
2013-02-28 - Bokslutskommuniké 2012
2012-11-26 - Kvartalsrapport 2012-Q3
2012-08-30 - Kvartalsrapport 2012-Q2
2012-05-28 - Kvartalsrapport 2012-Q1
2012-05-17 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2012-05-16 - Årsstämma
2012-02-29 - Bokslutskommuniké 2011
2011-11-28 - Kvartalsrapport 2011-Q3
2011-08-30 - Kvartalsrapport 2011-Q2
2011-05-30 - Kvartalsrapport 2011-Q1
2011-05-10 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2011-05-09 - Årsstämma
2011-02-25 - Bokslutskommuniké 2010
2010-05-11 - X-dag ordinarie utdelning AXIC A 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriPlast, kemikalier & fetter
aXichem är verksamt inom industriell bioteknik. Bolaget utvecklar, patenterar och marknadsför industrikemikalier. Bolaget arbetar framförallt med Fenylcapsaicin, en naturanalog syntetisk capsaicin med tillämpningar inom en mängd olika områden, såsom inom den marina sektorn, bland skadedjursbekämpning i skogs-och jordbruk, samt bland enskilda farmaceutiska arbetsområden. Verksamhet drivs på global nivå, med huvudkontoret i Malmö.
2025-04-16 08:50:00

aXichem AB (publ), (aXichem), developer of innovative natural analogue feed additives and dietary supplement ingredients, announces that the company, which is entering a growth phase and seeing increased demand for phenylcapsaicin, has decided to appoint Erik Lager as Chief Operating Officer (COO), to continue to ensure quality in orders, production and delivery during the company's commercial expansion. Erik Lager has been Chief Technology Officer (CTO) at aXichem since 2019.

Torsten Helsing, CEO of aXichem, comments:

"I am very pleased that Erik Lager is taking on the role of Chief Operating Officer. Erik has a good overview of aXichem's operations, and he has been a strong contributor to building the well-functioning logistics process that the company has today. As aXichem now enters a growth phase, it is important that Erik's role is clarified in the dialogue with customers and suppliers. The overall coordination of product adaptations, which takes place within the framework of our customer collaborations, will also be included under the role of Chief Operating Officer."

Erik Lager has a PhD in organic chemistry from Lund University and has worked as CTO and COO at Nexam Chemical Holding. Erik Lager has been a member of the company's management team since 2019 and holds 151,674 A shares in aXichem.

The information was submitted, through the care of the contact person below, for publication on 16 April 2025, at 08:50 AM CET.

Company contact:

Torsten Helsing, CEO, aXichem AB, Phone: +46 706 863 355 Email: torsten.helsing@axichem.com

About aXichem

aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.

More information is available at www.axichem.com